Jakafi (ruxolitinib tablets) — Cigna

Initial criteria

• Patient age ≥ 18 years
• Patient has tried hydroxyurea, Pegasys (peginterferon alfa-2a subcutaneous injection), or anagrelide

Approval duration

1 year